Life Science Investing Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635 28 October
Life Science Investing Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis 21 October
Life Science Investing Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA - the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia 07 October
